GLUT1 is an AR target contributing to tumor growth and glycolysis in castration-resistant and enzalutamide-resistant prostate cancers-Reference-Cited by-同舟云学术

GLUT1 is an AR target contributing to tumor growth and glycolysis in castration-resistant and enzalutamide-resistant prostate cancers

Published:2020-08 Issue: Volume:485 Page:45-55
ISSN:0304-3835
Container-title:Cancer Letters
language:en
Short-container-title:Cancer Letters

Author:

Wang Jun,Xu Wenhao^ORCID,Wang Beihe,Lin Guowen,Wei Yu,Abudurexiti Mierxiati,Zhu Wenkai,Liu Chang,Qin Xiaojian,Dai Bo,Wan Fangning,Zhang Hailiang,Zhu Yao,Ye Dingwei^ORCID

Funder

National Natural Science Foundation of China

Shanghai Key Disciplines Construction Program

Shanghai Rising-Star Program

Fudan University Shanghai Cancer Center

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference42 articles.

1. Duration of androgen suppression in the treatment of prostate cancer;Bolla;N. Engl. J. Med.,2009

2. Management of patients with advanced prostate cancer: report of the advanced prostate cancer consensus conference 2019;Gillessen;Eur. Urol.,2020

3. Update on systemic prostate cancer therapies: management of metastatic castration-resistant prostate cancer in the era of precision oncology;Nuhn;Eur. Urol.,2019

4. Managing nonmetastatic castration-resistant prostate cancer;Mateo;Eur. Urol.,2019

5. Enzalutamide in men with chemotherapy-naive metastatic castration-resistant prostate cancer: extended analysis of the phase 3 PREVAIL study;Beer;Eur. Urol.,2017

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The novel family of Warbicin® compounds inhibits glucose uptake both in yeast and human cells and restrains cancer cell proliferation;Frontiers in Oncology;2024-08-22

2. Targeting GLUT1 degradation with assembling glycopeptide for cancer inhibition;Chemical Engineering Journal;2024-08

3. Exploring a Gemcitabine-Glucose Hybrid as a Glycoconjugate Prodrug;ACS Omega;2024-07-09

4. Metabolic adaptations in prostate cancer;British Journal of Cancer;2024-07-05

5. Xihuang pills targeting the Warburg effect through inhibition of the Wnt/β-catenin pathway in prostate cancer;Heliyon;2024-06